Search alternatives:
patient decrease » point decrease (Expand Search), transient decrease (Expand Search), largest decrease (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
_ patient » _ patients (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
patient decrease » point decrease (Expand Search), transient decrease (Expand Search), largest decrease (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
_ patient » _ patients (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
-
1
-
2
Loss of Vps34 is associated with decreased eTreg survival but intact activation.
Published 2025Subjects: -
3
-
4
-
5
-
6
Elementary Steps in Olefin Metathesis: Nickelacyclobutanes via Cycloaddition to Nickel Carbenes
Published 2025Subjects: -
7
-
8
-
9
Decreased production of antiviral factors in patients infected with SARS-CoV-2 due to reduced TLR7 expression
Published 2025“…</p> <p>To investigate this, we analyzed the expression of interferon-stimulated genes (ISGs) in 48 SARS-CoV-2-infected patients using real-time polymerase chain reaction (RT-qPCR) and assessed toll-like receptor (TLR7) expression in blood cells via flow cytometry.…”
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Comparison of pre- and post-treatment evaluation results of patients.
Published 2025Subjects: “…disability subscores decreased…”
-
19
Comparison of pre- and post-treatment evaluation results of patients.
Published 2025Subjects: “…disability subscores decreased…”
-
20
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
Published 2025Subjects: